Brief: Avenue Therapeutics Received Notice From Nasdaq Notifying Co Is In Compliance With All Requirement Set Forth In Nasdaq Listing Rule 5550(B)(1)
23/05/2024 13:54
May 23 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS: RECEIVED NOTICE FROM NASDAQ
NOTIFYING CO
IS IN COMPLIANCE WITH ALL REQUIREMENT SET FORTH IN NASDAQ
LISTING RULE 5550(B)(1)
Source text for Eikon: ID:n0001437749-24-018072
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary